fda bpc-157 category 2 compounding Legit — Audit of the Body Protection Compound 157 Research Record The peptide comeback narrative has

BPC-157 is not FDA approved for any therapeutic indication as of April 2026

[1] Cell Signaling & Survival Pathway Research In vitro studies examine BPC-157s effects on: MAPK/ERK1/2 signaling cascade activation in cell culture models PI3K-Akt pathway interactions and downstream target phosphorylation Apoptosis regulation mechanisms in cellular assays Protein synthesis and metabolic activity pathways in tissue culture systems Laboratory investigations focus on Akt signaling pathway components and their roles in cell survival mechanisms

Material Safety Data Sheet (MSDS) - Supplied for safe handling

AOD-9604 works in the body on adipose tissue, also known as body fat tissue

Meola M, Petrucci I

Notwendig Statistik und Marketing